,ALOGPS_LOGP,ALOGPS_LOGS,ALOGPS_SOLUBILITY,CAS_NUMBER,DATABASE_ID,DATABASE_NAME,DRUGBANK_ID,EXACT_MASS,FORMULA,ID,INCHI_IDENTIFIER,INCHI_KEY,JCHEM_ACCEPTOR_COUNT,JCHEM_ATOM_COUNT,JCHEM_AVERAGE_POLARIZABILITY,JCHEM_BIOAVAILABILITY,JCHEM_DONOR_COUNT,JCHEM_FORMAL_CHARGE,JCHEM_GHOSE_FILTER,JCHEM_IUPAC,JCHEM_LOGP,JCHEM_MDDR_LIKE_RULE,JCHEM_NUMBER_OF_RINGS,JCHEM_PHYSIOLOGICAL_CHARGE,JCHEM_PKA,JCHEM_PKA_STRONGEST_ACIDIC,JCHEM_PKA_STRONGEST_BASIC,JCHEM_POLAR_SURFACE_AREA,JCHEM_REFRACTIVITY,JCHEM_ROTATABLE_BOND_COUNT,JCHEM_RULE_OF_FIVE,JCHEM_TRADITIONAL_IUPAC,JCHEM_VEBER_RULE,MOLECULAR_WEIGHT,Molecule,NAME,SMILES,UNII
858,3.08,-3.99,6.18e-02 g/l,,DBMET01054,drugbank,DBMET01054,605.272372568,C31H37N6O7,,"InChI=1S/C31H37N6O7/c1-2-3-10-22-32-31(15-6-7-16-31)30(43)36(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)27-33-35-37(34-27)28-25(40)23(38)24(39)26(44-28)29(41)42/h4-5,8-9,11-14,23-26,28,38-40H,2-3,6-7,10,15-17H2,1H3,(H,41,42)(H,33,34,35)/t23-,24-,25+,26-,28+/m0/s1",ARJSNKJRZKPXJE-NLMMERCGSA-N,0,,63.11185463345559,0,0,0,0,"(2S,3S,4S,5R,6R)-6-(5-{2-[4-({2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl}methyl)phenyl]phenyl}-2H-1,2,3λ⁵,4-tetrazol-3-yl)-3,4,5-trihydroxyoxane-2-carboxylic acid",,1,6,-1,,,,,168.43140000000005,9,0,"(2S,3S,4S,5R,6R)-6-(5-{2-[4-({2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl}methyl)phenyl]phenyl}-3H-1,2λ⁵,3,4-tetrazol-2-yl)-3,4,5-trihydroxyoxane-2-carboxylic acid",0,605.6615,,Irbesartan derivative M8,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN[N](=N1)[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O,
948,-0.77,-0.95,2.09e+01 g/l,,DBMET01148,drugbank,DBMET01148,185.024666825,C4H11ClN2O2P,,"InChI=1S/C4H11ClN2O2P/c5-1-2-7(3-4-7)10(6,8)9/h1-4H2,(H3,6,8,9)",AXYIDNWUNNCROG-UHFFFAOYSA-N,0,,15.898283381578175,1,0,0,0,amino[1-(2-chloroethyl)-1λ⁵-aziridin-1-yl]phosphinic acid,,0,1,0,,,,63.32000000000001,41.58710000000001,3,0,amino(1-(2-chloroethyl)-1λ⁵-aziridin-1-yl)phosphinic acid,0,185.569,,Phosphoramide Aziridinium,NP(O)(=O)[N]1(CCCl)CC1,
1168,2.21,-3.57,1.86e-01 g/l,,DBMET01385,drugbank,DBMET01385,688.261867444,C35H38N5O10,,"InChI=1S/C35H38N5O10/c1-38-14-16-40(17-15-38)19-26(41)39(2)23-11-9-22(10-12-23)36-28(20-6-4-3-5-7-20)27-24-13-8-21(18-25(24)37-32(27)44)34(47)50-35(48)30(43)29(42)31(49-50)33(45)46/h3-13,18,29-31,35-36,42-43,48H,14-17,19H2,1-2H3,(H,37,44)(H,45,46)/b28-27-",CNCQPKOQRWNHEB-DQSJHHFOSA-N,0,88,70.72651445214075,0,0,0,0,"4,5,6-trihydroxy-1-[(3Z)-2-hydroxy-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylidene]-3H-indole-6-carbonyl]-1λ³,2-dioxane-3-carboxylic acid",,1,6,0,,,,209.29,195.4799000000001,9,0,"4,5,6-trihydroxy-1-[(3Z)-2-hydroxy-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylidene]indole-6-carbonyl]-1λ³,2-dioxane-3-carboxylic acid",0,688.714,,BIBF 1202 glucuronide,CN(C(=O)CN1CCN(C)CC1)C1=CC=C(N\C(=C2/C(O)=NC3=C2C=CC(=C3)C(=O)[O]2OC(C(O)C(O)C2O)C(O)=O)C2=CC=CC=C2)C=C1,
1224,-0.16,-2.13,3.95e+00 g/l,,DBMET01452,drugbank,DBMET01452,536.03487175,C12H21N5O13P3,,"InChI=1S/C12H21N5O13P3/c1-5-15-11-7(10(13)16(5)2)14-4-17(11)12-9(19)8(18)6(28-12)3-27-32(23,24)30-33(25,26)29-31(20,21)22/h4,6,8-9,12,18-19H,3H2,1-2H3,(H2,13,15)(H,23,24)(H,25,26)(H2,20,21,22)/t6-,8-,9-,12-/m1/s1",ZXGQNOBWOMSFPK-WOUKDFQISA-N,0,54,43.79376459455785,0,0,0,0,"({[({[(2R,3S,4R,5R)-5-(6-amino-1,2-dimethyl-9H-1lambda4-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",,1,3,,,,,284.91999999999996,116.73179999999996,8,0,"({[(2R,3S,4R,5R)-5-(6-amino-1,2-dimethyl-1lambda4-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxyphosphonic acid",0,536.243,,DrugBank Test metabolite 1,CC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(N)=[N]1C,
1225,0.25,-2.17,3.79e+00 g/l,,DBMET01453,drugbank,DBMET01453,564.066171879,C14H25N5O13P3,,"InChI=1S/C14H25N5O13P3/c1-3-8-17-13-9(12(15)18(8)4-2)16-6-19(13)14-11(21)10(20)7(30-14)5-29-34(25,26)32-35(27,28)31-33(22,23)24/h6-7,10-11,14,20-21H,3-5H2,1-2H3,(H2,15,17)(H,25,26)(H,27,28)(H2,22,23,24)/t7-,10-,11-,14-/m1/s1",LKCRFPPZBDEFCV-FRJWGUMJSA-N,0,60,47.709370455361466,0,0,0,0,"({[({[(2R,3S,4R,5R)-5-(6-amino-1,2-diethyl-9H-1lambda4-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",,1,3,,,,,284.91999999999996,126.10729999999995,10,0,"({[(2R,3S,4R,5R)-5-(6-amino-1,2-diethyl-1lambda4-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxyphosphonic acid",0,564.297,,DrugBank test metabolite 2,CCC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(N)=[N]1CC,
1778,-0.42,-4.87,6.67e-03 g/l,,DBMET02053,drugbank,DBMET02053,489.182123516,C25H31NO7S,,"InChI=1S/C25H31NO7S/c1-26(33-23(24(30)31)21(28)20(27)22(29)25(33)32)11-8-15(9-12-26)19-16-5-3-2-4-14(16)6-7-18-17(19)10-13-34-18/h2-5,10,13,20-23,25,27-29,32H,6-9,11-12H2,1H3,(H,30,31)/t20-,21-,22+,23-,25?/m0/s1",IHQMERKHASLAPX-UKZGQZPXSA-N,0,65,51.24412166288409,1,0,0,0,"(2S,3S,4S,5R)-3,4,5,6-tetrahydroxy-1-(1-methyl-4-{6-thiatricyclo[8.4.0.0^{3,7}]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene}-1lambda4-piperidin-1-yl)-1lambda3-oxane-2-carboxylic acid",,0,5,0,,,,131.81,148.99010000000007,2,0,"(2S,3S,4S,5R)-3,4,5,6-tetrahydroxy-1-(1-methyl-4-{6-thiatricyclo[8.4.0.0^{3,7}]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene}-1lambda4-piperidin-1-yl)-1lambda3-oxane-2-carboxylic acid",0,489.58,,Pizotifen glucuronide,C[N]1(CCC(CC1)=C1C2=C(CCC3=CC=CC=C13)SC=C2)[O]1C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1C(O)=O,
1779,1.48,-3.45,1.74e-01 g/l,,DBMET02054,drugbank,DBMET02054,484.0202115,C20H16Cl2NO9,,"InChI=1S/C20H16Cl2NO9/c21-9-3-8(4-10(22)6-9)17-23-11-2-1-7(5-12(11)31-17)19(29)32-16(18(27)28)14(25)13(24)15(26)20(32)30/h1-6,13-16,20,24-26,30H,(H,27,28)/t13-,14-,15+,16-,20?/m0/s1",SKPGABZWBBQXOO-BUBSSSHASA-N,0,48,45.14626534520633,1,0,0,0,"(2S,3S,4S,5R)-1-[2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carbonyl]-3,4,5,6-tetrahydroxy-1lambda3-oxane-2-carboxylic acid",,0,4,0,,,,174.91,129.69929999999997,4,0,"(2S,3S,4S,5R)-1-[2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carbonyl]-3,4,5,6-tetrahydroxy-1lambda3-oxane-2-carboxylic acid",0,485.25,,Tafamidis Acylglucuronide metabolite,O[C@@H]1[C@@H](O)C(O)[O]([C@@H]([C@H]1O)C(O)=O)C(=O)C1=CC2=C(C=C1)N=C(O2)C1=CC(Cl)=CC(Cl)=C1,
1781,4.24,-5.65,1.92e-03 g/l,,DBMET02056,drugbank,DBMET02056,832.386434241,C45H54F2N4O9,,"InChI=1S/C45H54F2N4O9/c1-8-42-14-11-16-50-17-15-43(36(42)50)30-19-31(34(57-5)20-33(30)49(4)37(43)45(55,40(54)59-7)38(42)60-25(2)52)44(39(53)58-6)21-26-18-27(41(3,46)47)23-51(56,22-26)24-29-28-12-9-10-13-32(28)48-35(29)44/h9-14,19-20,26-27,36-38,48,55H,8,15-18,21-24H2,1-7H3/q-1/t26-,27+,36-,37+,38+,42+,43+,44-,45-/m0/s1",MEHVBJQZFXQBJH-KLCPSUAYSA-N,0,114,87.33833815399944,0,0,-1,0,"(1R,12S,14S,16R)-12-[(1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-10-hydroxy-5-methoxy-10-(methoxycarbonyl)-8-methyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6,13-tetraen-4-yl]-16-(1,1-difluoroethyl)-12-(methoxycarbonyl)-1lambda4,10-diazatetracyclo[12.3.1.0^{3,11}.0^{4,9}]octadeca-3(11),4,6,8-tetraen-1-olate",,1,9,,,,,153.69,218.57139999999995,10,0,"(1R,12S,14S,16R)-12-[(1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-10-hydroxy-5-methoxy-10-(methoxycarbonyl)-8-methyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6,13-tetraen-4-yl]-16-(1,1-difluoroethyl)-12-(methoxycarbonyl)-1lambda4,10-diazatetracyclo[12.3.1.0^{3,11}.0^{4,9}]octadeca-3(11),4,6,8-tetraen-1-olate",0,832.943,,N-oxide-vinflunine,CC[C@@]12C=CCN3CC[C@@]4([C@H]13)[C@@H](N(C)C1=CC(OC)=C(C=C41)[C@]1(C[C@@H]3C[C@H](C[N@]([O-])(C3)CC3=C1NC1=CC=CC=C31)C(C)(F)F)C(=O)OC)[C@](O)([C@@H]2OC(C)=O)C(=O)OC,
